GlassScriptPhysician profile
Christine Wu
NPI 1164635702
$381.63
in general payments reported to CMS, 2019-2025
11 companies · $54.81 in 2025
The $54.81 reported for 2025 was less than what a typical Adolescent Medicine (Pediatrics) provider received nationally (typical 2025 total: $99.31).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $126 · 2020: $23.65 · 2022: $101 · 2024: $76.59 · 2025: $54.81.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $131.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $131.40 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Incyte Corporation | $91.79 | 2022-2025 | Opzelura |
| Pfizer INC. | $81.68 | 2019-2025 | |
| Allergan, INC. | $45.99 | 2019 | |
| Cranial Technologies, INC | $29.75 | 2019-2024 | Doc Band |
| Glaxosmithkline, LLC. | $23.65 | 2020 | |
| Ironshore Pharmaceuticals INC. | $21.35 | 2024 | |
| Otsuka America Pharmaceutical, INC. | $20.55 | 2019 | |
| Phadia US INC. | $18.91 | 2024 | Immunocap |
| Ars Pharmaceuticals Operations, INC. | $16.51 | 2025 | Neffy |
| Daiichi Sankyo INC. | $16.36 | 2019 | |
| Coopersurgical, INC. | $15.09 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christine Wu listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.